Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.2K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

589
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
589
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

197
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
197
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

313
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
313
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

81
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
81
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

1.3K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

'Challenges in pediatric medicine access in Albania: insights from community Pharmacists'.

Journal of pharmaceutical policy and practice·2025
Same author

Time and cost involved in measuring access to medicines: the case of Albania.

BMC research notes·2025
Same author

A proposed analytical framework for qualitative evaluation of access to medicines from a health systems perspective.

BMC research notes·2024
Same author

The caregiver's experience of childhood cancer treatment in South Africa.

Journal of pharmaceutical policy and practice·2024
Same author

Outer packaging labelling of medicines in Southern African Development Community (SADC) countries: comparative analysis of requirements and transition terms for harmonisation.

BMC health services research·2024
Same author

Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children.

Journal of pharmaceutical policy and practice·2024

Related Experiment Video

Updated: Jul 31, 2025

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

8.5K

Pharmaceutical Scientists' Perspectives on Capacity Building in Pharmaceutical Sciences.

Z Kusynová1, H A van den Ham2, H G M Leufkens2

  • 1Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands; International Pharmaceutical Federation (FIP), The Hague, the Netherlands.

Journal of Pharmaceutical Sciences
|May 3, 2023
PubMed
Summary

Strengthening pharmaceutical sciences education and aligning research with patient needs are key to building workforce capacity. This ensures the field can adapt to future health challenges and technological advancements.

Keywords:
Capacity buildingGlobal healthPharmaceutical sciencesResearch policy

More Related Videos

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
09:39

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Published on: December 27, 2016

17.8K
Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience
10:17

Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience

Published on: November 15, 2024

1.1K

Related Experiment Videos

Last Updated: Jul 31, 2025

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

8.5K
A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
09:39

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Published on: December 27, 2016

17.8K
Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience
10:17

Improving Student Outcomes with an Adaptable Molecular Cloning Course-Based Undergraduate Research Experience

Published on: November 15, 2024

1.1K

Area of Science:

  • Pharmaceutical Sciences
  • Health Workforce Development

Background:

  • Ensuring a robust pharmaceutical sciences workforce is crucial for addressing future health challenges.
  • Strategic workforce planning requires identifying key drivers for capacity building.

Purpose of the Study:

  • To identify critical drivers for capacity building in pharmaceutical sciences research.
  • To inform strategic decisions and workforce planning in the field.

Main Methods:

  • A global questionnaire survey was distributed to 92 internationally renowned pharmaceutical scientists.
  • Participants were primarily from academia and the pharmaceutical industry with pharmacy backgrounds.

Main Results:

  • The top identified drivers for capacity building were better alignment with patient needs and strengthening education.
  • Education strengthening includes continuous learning and deeper specialization.
  • Capacity building requires flexibility, adaptation to clinical changes, and lifelong learning, not just increased graduate numbers.

Conclusions:

  • Pharmaceutical sciences are increasingly interdisciplinary, necessitating diverse scientific backgrounds.
  • Future capacity building must emphasize adaptability, specialized scientific needs, and continuous professional development.